Shanxi C&Y Pharmaceutical Group Co Ltd (300254) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a cash flow conversion efficiency ratio of 0.092x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.93 Million ≈ $7.75 Million USD) by net assets (CN¥577.09 Million ≈ $84.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300254 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Shanxi C&Y Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanxi C&Y Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Infosec Technologies Co. Ltd. A
SHG:688201
|
N/A |
|
Lanzhou Zhuangyuan Pasture Co Ltd
SHE:002910
|
0.059x |
|
Morguard Real Estate Investment Trust
TO:MRT-UN
|
0.006x |
|
Seah Holdings
KO:058650
|
-0.012x |
|
ZheJiang BangJie Digital Knitting Share Co Ltd
SHE:002634
|
-0.008x |
|
ADD Industry Zhejiang Co Ltd
SHG:603089
|
0.012x |
|
Maui Land & Pineapple Company Inc
NYSE:MLP
|
-0.028x |
|
Esso (Thailand) Public Company Limited
BK:BSRC
|
0.222x |
Annual Cash Flow Conversion Efficiency for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Shanxi C&Y Pharmaceutical Group Co Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥594.33 Million ≈ $86.97 Million |
CN¥96.77 Million ≈ $14.16 Million |
0.163x | +37.29% |
| 2024-12-31 | CN¥598.18 Million ≈ $87.53 Million |
CN¥70.94 Million ≈ $10.38 Million |
0.119x | +144.13% |
| 2023-12-31 | CN¥778.43 Million ≈ $113.91 Million |
CN¥37.81 Million ≈ $5.53 Million |
0.049x | -52.66% |
| 2022-12-31 | CN¥729.68 Million ≈ $106.78 Million |
CN¥74.88 Million ≈ $10.96 Million |
0.103x | -21.17% |
| 2021-12-31 | CN¥744.58 Million ≈ $108.96 Million |
CN¥96.92 Million ≈ $14.18 Million |
0.130x | +644.07% |
| 2020-12-31 | CN¥872.61 Million ≈ $127.69 Million |
CN¥-20.88 Million ≈ $-3.05 Million |
-0.024x | -132.04% |
| 2019-12-31 | CN¥932.60 Million ≈ $136.47 Million |
CN¥69.63 Million ≈ $10.19 Million |
0.075x | +80.88% |
| 2018-12-31 | CN¥931.24 Million ≈ $136.27 Million |
CN¥38.44 Million ≈ $5.63 Million |
0.041x | -0.04% |
| 2017-12-31 | CN¥971.17 Million ≈ $142.11 Million |
CN¥40.10 Million ≈ $5.87 Million |
0.041x | -5.33% |
| 2016-12-31 | CN¥954.85 Million ≈ $139.72 Million |
CN¥41.65 Million ≈ $6.09 Million |
0.044x | +146.44% |
| 2015-12-31 | CN¥872.50 Million ≈ $127.67 Million |
CN¥15.44 Million ≈ $2.26 Million |
0.018x | -82.27% |
| 2014-12-31 | CN¥823.16 Million ≈ $120.45 Million |
CN¥82.19 Million ≈ $12.03 Million |
0.100x | -4.94% |
| 2013-12-31 | CN¥767.16 Million ≈ $112.26 Million |
CN¥80.58 Million ≈ $11.79 Million |
0.105x | +95.14% |
| 2012-12-31 | CN¥651.17 Million ≈ $95.29 Million |
CN¥35.05 Million ≈ $5.13 Million |
0.054x | +558.60% |
| 2011-12-31 | CN¥581.17 Million ≈ $85.04 Million |
CN¥4.75 Million ≈ $695.08K |
0.008x | -97.65% |
| 2010-12-31 | CN¥149.59 Million ≈ $21.89 Million |
CN¥52.03 Million ≈ $7.61 Million |
0.348x | -61.24% |
| 2009-12-31 | CN¥117.60 Million ≈ $17.21 Million |
CN¥105.55 Million ≈ $15.45 Million |
0.898x | +344.54% |
| 2008-12-31 | CN¥106.70 Million ≈ $15.61 Million |
CN¥-39.16 Million ≈ $-5.73 Million |
-0.367x | -- |
About Shanxi C&Y Pharmaceutical Group Co Ltd
ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, comme… Read more